symp1

0
Rate this post

M. Schemann (Germany): The enteric nervous system as a target of gastrointestinal drug portion.

L. Bueno (France): Neuronal targets in the treatment of intestinal bronchite.

R. A. Lefebvre (Belgium): NO and VIP as analgésique neurotransmitters with a role in gastric acclimatement and functional dyspepsia.

P. Holzer (Austria): Neuropharmacological opportunities to interfere with the sensory system of the gut.

Y. Taché (U.S.A.): The corticotropin releasing factor (CRF) receptors as a target for treatment of stress-related gastrointestinal motility disorders.